Mylan: Seeing is Believing

menu

Financials & Filings

Financials & Filings

Filing date	Form	Filing Group	View
Mar 6, 2018	4	3,4,5	View HTML 0000899243-18-006551.pdf
Mar 6, 2018	4	3,4,5	View HTML 0000899243-18-006554.pdf
Mar 1, 2018	10-K	Annual Filings	View HTML 0001623613-18-000010.pdf 0001623613-18-000010.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Feb 28, 2018	8-K	Current Reports	View HTML 0001623613-18-000008.pdf 0001623613-18-000008.xls
Feb 26, 2018	8-K	Current Reports	View HTML 0001193125-18-058627.pdf 0001193125-18-058627.xls
Feb 23, 2018	4	3,4,5	View HTML 0000899243-18-005373.pdf
Feb 23, 2018	4	3,4,5	View HTML 0000899243-18-005370.pdf
Feb 23, 2018	4	3,4,5	View HTML 0000899243-18-005372.pdf
Feb 23, 2018	4	3,4,5	View HTML 0000899243-18-005369.pdf
Feb 21, 2018	4	3,4,5	View HTML 0000899243-18-004914.pdf

Mylan N.V. became the successor registrant to Mylan Inc. as of February 27, 2015. The public filings set forth on this page include the filings of both Mylan N.V. and Mylan Inc.

Email Alerts

Investor FAQs

Contact Us

LinkedIn

Resources and information to help prescribe, dispense and take medicine with confidence.

Pharmacists

Educational materials to help empower your customers.
Patients

What to know about our high quality generics.
Physicians

Details about our brand name and generic medicines.
Institutional Customers

Resources that meet the specific needs of your institution.

Explore

Copyright © 2018 Mylan N.V. All Rights Reserved.

For U.S. Audiences Only